| D09535 | |
| D number | D09535 |
| Classification | Drug |
| Name | Mirabegron (USAN/JAN); Myrbetriq (TN) |
| Component | - |
| Formula | C21H24N4O2S |
| Exact mass | 396.162 |
| Mol weight | 396.5059 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Cardiovascular agent DG01456 Adrenergic receptor agonist DG01455 beta-Adrenergic receptor agonist DG01453 beta3-Adrenergic receptor agonist Cyp inhibitor DG01645 CYP2D6 inhibitor |
| Remark | Therapeutic category: 2590 ATC code: G04BD12 Chemical group: DG02555 |
| Activity | - |
| Disease | - |
| Comment | - |
| Target | ADRB3 [HSA:155] [KO:K04143] |
| Metabolism | Enzyme: CYP3A4 [HSA:1576] |
| Interaction | CYP inhibition: CYP2D6 [HSA:1565] |
| Other DBs | CAS: 223673-61-8 PubChem: 96026215 ChEBI: 65349 ChEMBL: CHEMBL2095212 LigandBox: D09535 |
| KCF data | - |